Follow-up study of L059 (levetiracetam) in epileptic patients with partial onset seizures by open label method.
Phase of Trial: Phase III
Latest Information Update: 12 Mar 2015
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors UCB Pharma Inc
- 15 Jan 2008 Status changed from in progress to completed.
- 03 Dec 2005 New trial record.